数字健康现状 全球 | 2026年第一季度 全球私募市场数字医疗企业的交易、融资及退出数据与分析

State ofDigital Health Global | Q1 2026 Global data and analysis on dealmaking, funding,and exits by private market digital health companies Insights are good.Action is better. We track and compare the world’s companies. Our AIagents keep you a step ahead of competitors anddisruption. Trusted by the world's smartest companies:Every big tech company. Every top professionalservices firm. 26 of the top 30 banks. All ten Fortune10 companies. Put our AI agents to work today. ▮▮▮▮IIIIIIStart free trial Go Deeper. All the data behind this report is live on the CB Insightsplatform. Filter it, download it, build your own analysis. ▮▮▮▮IIIIIIExplore the data TL;DRYour rundown ondigital healthinQ1’26TL;DR $7.4B +47%Jump in M&AactivityQoQ. 23% Of quarterly funding wentto AI indrugdiscovery. +59% Headcount growthin healthcareAI. Highestglobalfundingsince Q2'22. Digital health M&A surged to 56deals in Q1'26, up from 38 inQ4'25, with buyers reservingpremium valuations for companieswith strong commercial traction,not just regulatory approval. Quarterly funding hit $7.4B, a 25%QoQ increase from Q4'25, butgains are concentrating fast.Mega-rounds ($100M+) captureda record 60% of all capital acrossjust 19 deals, as average deal sizeclimbed to $29.6M, up 47% YoY. Healthcare AI model developersgrew headcount faster than anyother digital health market, withspecialized startups and AI giantsconverging on the sameopportunity. Big pharma partnered withestablished discovery platformstoaccelerate R&D timelines—EarendilLabs raised $787Mbacked by Pfizer and Sanofi, whileTakeda partnered with IambicTherapeutics in a relationshipworth up to $1.7B. Abbott's $23B acquisition ofExact Sciences andDeepHealth's$269M Gleamer deal underscorethat regulatory clearance is tablestakes, commercial scale drivesprice. Tennrled the way with 133% YoYgrowth, pushing into new clinicalverticals, while Anthropiccontinuesto accelerate its hiringfor healthcare-specific roles. Eight new unicorns emerged inQ1'26—the highest single-quartercount since Q2'22. Early-stage capital took a differentbet: platforms engineering entirelynew drug classes. See the data→ See the data→ See the data→ See the data→ TL;DRState ofDigital Health Mega-roundsmade up a recordshare of digitalhealth funding inQ1 2026 TL;DRState ofDigital Health Late-stage digitalhealth deal sizesare pulling awayfrom the rest ofthe market Quarterly median deal size by stage TL;DRState ofDigital Health Digital health M&Arebounds sharplyin Q1'26, up 47%from Q4’25 lows TL;DRState ofDigital Health The priorauthorization stackmobilizes ahead ofthe 2027 CMSdeadline TL;DRState ofDigital Health AI in drug discoveryrepresents agrowing share ofdigital healthfunding TL;DRState ofDigital Health Healthcare AImodel developersare the fastest-growing digitalhealth market byheadcount State of Digital Health Q1’26© 2026 CB Insights. TL;DRState ofDigital Health Nvidia is buildingtoward becomingthe compute layeracross healthcareAI verticals Nvidia’s acquisitions, investments, andpartnerships over the last 6 months State of Digital Health Q1’26©2026 CB Insights.Recent partnerships partnerships span care delivery, diagnostics, drug discovery, and robotics. Not exhaustive ofall ofNvidia’s business relationships ContentsState of Digital Health GlobalTrends13 InvestmentTrends14HeadcountTrends37Unicorns44ExitTrends50Investors55 GeographicTrends59 US60SiliconValley66NewYork70Boston74Asia78China84India88Japan92Europe96UnitedKingdom102 Global Trends Investment Trends State of Digital Health|Global Trends|Investment Trends Annual equity funding & deals State of Digital Health|Global Trends|Investment Trends Quarterly equity funding & deals State of Digital Health|Global Trends|Investment Trends Funding & deals by global region in Q1’26 State of Digital Health|Global Trends|Investment Trends Percent of quarterly deals by global region State of Digital Health|Global Trends|Investment Trends Percent of quarterly deals by investor group State of Digital Health|Global Trends|Investment Trends Annual average & median deal size State of Digital Health|Global Trends|Investment Trends Annual median deal size by global region State of Digital Health|Global Trends|Investment Trends Annual median deal size by investor group Quarterly funding & deals from mega-rounds (deals worth $100m+) State of Digital Health|Global Trends|Investment Trends State of Digital Health|Global Trends|Investment Trends Quarterly mega-round deals by global region State of Digital Health|Global Trends|Investment Trends Quarterly mega-rounds as percent of funding State of Digital Health|Global Trends|Investment Trends Annual percent of deals by deal stage State of Digital Health|Global Trends|Investment Trends Regional deal share by deal stage in Q1’26 Annual median funding by deal stage Global: Top Series A deals in Q1’26 Global: Top Series C deals in Q1’26 Global: Top Series D deals in Q